rs770842374
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001849.4(COL6A2):c.115+2T>C variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,606,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001849.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.115+2T>C | splice_donor_variant, intron_variant | ENST00000300527.9 | NP_001840.3 | |||
COL6A2 | NM_058174.3 | c.115+2T>C | splice_donor_variant, intron_variant | NP_478054.2 | ||||
COL6A2 | NM_058175.3 | c.115+2T>C | splice_donor_variant, intron_variant | NP_478055.2 | ||||
LOC124905043 | XR_007067910.1 | n.439A>G | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.115+2T>C | splice_donor_variant, intron_variant | 1 | NM_001849.4 | ENSP00000300527.4 | ||||
COL6A2 | ENST00000397763.6 | c.115+2T>C | splice_donor_variant, intron_variant | 5 | ENSP00000380870.1 | |||||
COL6A2 | ENST00000409416.6 | c.115+2T>C | splice_donor_variant, intron_variant | 5 | ENSP00000387115.1 | |||||
COL6A2 | ENST00000436769.5 | c.115+2T>C | splice_donor_variant, intron_variant | 2 | ENSP00000390418.1 |
Frequencies
GnomAD3 genomes AF: 0.0000200 AC: 3AN: 150258Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.00000811 AC: 2AN: 246556Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134548
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1456712Hom.: 0 Cov.: 30 AF XY: 0.00000966 AC XY: 7AN XY: 724878
GnomAD4 genome AF: 0.0000200 AC: 3AN: 150258Hom.: 0 Cov.: 30 AF XY: 0.0000273 AC XY: 2AN XY: 73276
ClinVar
Submissions by phenotype
Collagen 6-related myopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2019 | The COL6A2 c.115+2T>C variant occurs in a canonical splice site (donor) and is therefore predicted to disrupt or distort the normal gene product. This variant has been reported in two studies and is found in four affected individuals, including a sibling pair, one in a homozygous state and three in a compound heterozygous state. All individuals had collagen type VI spectrum disorders, two of whom were classified as moderate progressive (Brinas et al. 2010; Fraser et al. 2017). This variant is found at a frequency of 0.000294 in the Ashkenazi Jewish population of the Genome Aggregation Database. Based on the evidence, the c.115+2T>C variant is classified as likely pathogenic for recessively inherited collagen type VI-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Bethlem myopathy 1A Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 17, 2023 | This sequence change affects a donor splice site in intron 2 of the COL6A2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in COL6A2 are known to be pathogenic (PMID: 19884007, 20976770). This variant is present in population databases (rs770842374, gnomAD 0.02%). Disruption of this splice site has been observed in individuals with autosomal recessive collagen VI myopathy (PMID: 20976770). ClinVar contains an entry for this variant (Variation ID: 476449). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 27, 2023 | Published functional studies demonstrate significantly reduced COL6A2 mRNA expression (Brinas et al., 2010; Butterfield et al., 2017); Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28660205, 16199547, 19884007, 20976770, 29244830) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at